Rebecca Auer

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Clinical Practice

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, Shirley D'Sa, Guy Pratt, Gavin Campbell, Lauren Campbell, Ross Sadler, William Townsend, Bilyana Popova, Paul Smith, Oliver Schofield, Roger Owen, Rebecca Auer
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. Leukemia (2024)
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, Shirley D'Sa, Guy Pratt, Gavin Campbell, Lauren Campbell, Ross Sadler, William Townsend, Bilyana Popova, Paul Smith, Oliver Schofield, Roger Owen, Rebecca Auer
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. Leukemia 38 (4) (2024)
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, Shirley D'Sa, Guy Pratt, Gavin Campbell, Lauren Campbell, Ross Sadler, William Townsend, Bilyana Popova, Paul Smith, Oliver Schofield, Roger Owen, Rebecca Auer
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. Leukemia 38 (4) (2024)
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, Shirley D'Sa, Guy Pratt, Gavin Campbell, Lauren Campbell, Ross Sadler, William Townsend, Bilyana Popova, Paul Smith, Oliver Schofield, Roger Owen, Rebecca Auer
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. Leukemia 38 (4) (2024)
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, Shirley D'Sa, Guy Pratt, Gavin Campbell, Lauren Campbell, Ross Sadler, William Townsend, Bilyana Popova, Paul Smith, Oliver Schofield, Roger Owen, Rebecca Auer
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia. Leukemia 38 (4) (2024)
Pier Luigi Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Roderick Johnson, Alejandro Martin Martin Garcia-Sancho, Mariano Provencio Pulla, Marek Trněný, Sam Yuen, Herve Tilly, Edwin Kingsley, Gayane Tumyan, Sarit E Assouline, Rebecca Auer, Elena Ivanova, Pil Kim, Sha Huang, Richard Delarue, Judith Trotman
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)